Chemical pathology of acute demyelinating lesions and its correlation with disability

被引:255
作者
DeStefano, N
Matthews, PM
Antel, JP
Preul, M
Francis, G
Arnold, DL
机构
[1] MONTREAL NEUROL HOSP & INST, DEPT NEUROL & NEUROSURG, MONTREAL, PQ H3A 2B4, CANADA
[2] MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ, CANADA
关键词
D O I
10.1002/ana.410380610
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report the chemical pathological changes on magnetic resonance spectroscopic images of 4 patients, each of whom had a single large demyelinating plaque. The patients were followed from soon after the onset of the symptoms for a minimum of 7 months to a maximum of 31/2 years. We observed increases in the relative resonance intensities of choline-containing compounds, lactate, and myo-inositol inside the lesion acutely. Decreases in relative resonance intensities of N-acetylaspartate and creatine were seen both in and around the magnetic resonance imaging-detected lesions. In all patients neurological deficits improved and creatine, lactate, and myo-inositol resonance intensities normalized during the follow-up. Choline compounds recovered more slowly and were still abnormally high in 1 patient after 7 months. Partial recovery of the N-acetylaspartate resonance was seen for all patients. Evaluation of the relationships between indices of cerebral chemical pathology, brain lesion volumes, and functional disability showed highly significant negative correlations between N-acetylaspartate resonance intensities and both brain lesion volumes (r = -0.80, P < 0.0001) and clinical disability (r = -0.73, P < 0.0001). As N-acetylaspartate is localized solely in neurons in the adult central nervous system, our results suggest that neuronal dysfunction may be a proximate mechanism of disability even in inflammatory disorders primarily affecting myelin and oligodendroglial cells.
引用
收藏
页码:901 / 909
页数:9
相关论文
共 37 条
[11]  
DENHOLLANDER JA, 1991, P SOC MAGN RESON MED, V1, P472
[12]  
DESTEFANO N, IN PRESS MAGN RESON
[13]  
DOYLE T, 1993, P SOC MAGN RESON MED, V3, P1551
[14]   CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRI ACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY [J].
FILIPPI, M ;
PATY, DW ;
KAPPOS, L ;
BARKHOF, F ;
COMPSTON, DAS ;
THOMPSON, AJ ;
ZHAO, GJ ;
WILES, CM ;
MCDONALD, WI ;
MILLER, DH .
NEUROLOGY, 1995, 45 (02) :255-260
[15]   REMYELINATION IN THE HUMAN CENTRAL NERVOUS-SYSTEM [J].
GHATAK, NR ;
LESHNER, RT ;
PRICE, AC ;
FELTON, WL .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (05) :507-518
[16]   SERIAL GADOLINIUM-ENHANCED MAGNETIC-RESONANCE-IMAGING SCANS IN PATIENTS WITH EARLY, RELAPSING-REMITTING MULTIPLE-SCLEROSIS - IMPLICATIONS FOR CLINICAL-TRIALS AND NATURAL-HISTORY [J].
HARRIS, JO ;
FRANK, JA ;
PATRONAS, N ;
MCFARLIN, DE ;
MCFARLAND, HF .
ANNALS OF NEUROLOGY, 1991, 29 (05) :548-555
[17]   BIOCHEMICAL-ALTERATIONS IN MULTIPLE-SCLEROSIS LESIONS AND NORMAL-APPEARING WHITE-MATTER DETECTED BY IN-VIVO P-31 AND H-1 SPECTROSCOPIC IMAGING [J].
HUSTED, CA ;
GOODIN, DS ;
HUGG, JW ;
MAUDSLEY, AA ;
TSURUDA, JS ;
DEBIE, SH ;
FEIN, G ;
MATSON, GB ;
WEINER, MW .
ANNALS OF NEUROLOGY, 1994, 36 (02) :157-165
[18]   SYSTEMIC LYMPHOBLASTOID INTERFERON THERAPY IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS .1. CLINICAL AND MRI EVALUATION [J].
KASTRUKOFF, LF ;
OGER, JJ ;
HASHIMOTO, SA ;
SACKS, SL ;
LI, DK ;
PALMER, MR ;
KOOPMANS, RA ;
PETKAU, AJ ;
BERKOWITZ, J ;
PATY, DW .
NEUROLOGY, 1990, 40 (03) :479-486
[19]   LONGITUDINAL MRI IN MULTIPLE-SCLEROSIS - CORRELATION BETWEEN DISABILITY AND LESION BURDEN [J].
KHOURY, SJ ;
GUTTMANN, CRG ;
ORAV, EJ ;
HOHOL, MJ ;
AHN, SS ;
HSU, L ;
KIKINIS, R ;
MACKIN, GA ;
JOLESZ, FA ;
WEINER, HL .
NEUROLOGY, 1994, 44 (11) :2120-2124
[20]   MAGNETIC-RESONANCE SPECTROSCOPY OF MULTIPLE-SCLEROSIS - INVIVO DETECTION OF MYELIN BREAKDOWN PRODUCTS [J].
KOOPMANS, RA ;
LI, DKB ;
ZHU, G ;
ALLEN, PS ;
PENN, A ;
PATY, DW .
LANCET, 1993, 341 (8845) :631-632